Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Agios Pharmaceuticals (8AP.F) Q3 2025 Earnings
8AP.F
31
Jul
Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.69
3.84
9.37
14.9
Details
Expected EPS
-1.58260322
Actual EPS
-1.689908
Surprise EPS
-0.11
Surprise Percent
+6.78%
Description
Agios Pharmaceuticals (8AP.F) has reported earnings of -1.689908 per share for Q3 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login